Investors have gotten used to seeing the Nasdaq Composite ( NASDAQINDEX:^IXIC ) chart its own path, and Thursday was no exception. Even as other major market benchmarks headed lower, the Nasdaq managed to post gains of 0.3% as of 12:45 p.m. EST, once again demonstrating why it has been able to provide so much outperformance throughout 2020. Among top Nasdaq stocks, Tesla ( NASDAQ:TSLA ) continued to get a lot of attention from investors, many of whom appear to be positioning themselves ahead of the forced buying from index fund managers next month. Yet the truly large gains were reserved for Sonos ( NASDAQ:SONO ) , which released extremely encouraging financial results that make the speaker maker sound like an interesting investment to many. Can Tesla keep climbing? Tesla shares were up another 2% early Thursday afternoon, after having been up as much as 5% earlier in the session. At its best levels of the day, Tesla touched all-time highs above the $500 …
ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks
The stock market posted mixed results on Friday morning, as investors continued to wrestle with countervailing factors in making their investment decisions. As of 11:45 a.m. EDT, the Nasdaq Composite ( NASDAQINDEX:^IXIC ) was trailing other major benchmarks, falling about a quarter percent. The biotech industry is well represented on the Nasdaq, and it can be a high-risk, high-reward industry for investors. Good news can send a biotech stock soaring, while disappointment can crush share prices. Today, the Nasdaq provided two great examples of how that can play out, as ChemoCentryx ( NASDAQ:CCXI ) and Allogene Therapeutics ( NASDAQ:ALLO ) revealed both sides of the coin. Below, we'll look more closely at what happened with these two stocks. Image source: Getty Images. ChemoCentryx gets a big win Shares of ChemoCentryx had soared 68% by midday on Friday. The biotech company announced a key win for its lead candidate treatment. The Food and Drug …
Continue Reading about ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks →
Don’t Buy MercadoLibre for Its E-Commerce Business, Buy It for This Instead
E-commerce giant MercadoLibre ( NASDAQ:MELI ) has spent two decades steadily building its e-commerce marketplace and logistics network to become the leading retailer in Latin America. The stock has rewarded investors with a 2,500% gain over the past decade. The company's growth runway remains intact for its e-commerce business, but it's no longer the only star of the show. Its fintech business could be what drives returns on the stock in the future; here are two reasons. Image Source: Getty Images 1. Banking infrastructure is lacking in Latin America The financial infrastructure in Latin America is underdeveloped compared to more mature markets like the United States. While roughly 95% of U.S. households have banking services, countries throughout Latin America still lack banking access. Banking penetration rates are under 90% throughout the region, led by Brazil at 88%, but countries like Argentina, Columbia, and Mexico lag far behind. MercadoLibre's Mercado Pago …
Continue Reading about Don’t Buy MercadoLibre for Its E-Commerce Business, Buy It for This Instead →
2 Stocks to Consider for E-Commerce and Digital Payments Growth in Latin America
StoneCo ( NASDAQ:STNE ) and MercadoLibre ( NASDAQ:MELI ) are leaders in the e-commerce and digital payments spaces in Latin America. Their stocks have not performed particularly well this year, though -- but that doesn't mean they won't be long-term winners. In this Motley Fool Live segment from "The 5" recorded Oct. 8 , Fool.com contributors Jason Hall, Jeremy Bowman, and Nicholas Rossolillo discuss why the future still looks bright for both tech firms. Jeremy Bowman: Let's talk about what your favorite international stock -- your favorite non-U.S. stock -- is right now. Nick, let's go to you. Nicholas Rossolillo: I don't have to defer for that long. [laughs] You asked about StoneCo. Man, what a disaster. Let's preface my pitch here with a chart that you never want to see. StoneCo, since they went public in late 2018, a pretty good run through the first month or two of 2021, and then, the last year-to-date has just been a disaster. You don't want to see …
Why HubSpot Stock Is Falling Today
What happened Shares of HubSpot ( NYSE:HUBS ) were falling today as the 10-year Treasury yield increased to 1.5%, the highest it's been since June. The tech stock fell by as much as 6.4% this morning and was down by 4.6% as of noon EDT. So what Rising Treasury yields are often viewed as a negative thing for fast-growing technology stocks because they mean that debt spending will cost more for companies, eating into their long-term growth potential. Image source: Getty Images. That appears to be what's happening with HubSpot's stock today, along with many other technology stocks. The Nasdaq Composite , which is largely composed of tech stocks, fell by more than 1% this morning, though it had regained some of its losses by midafternoon. Some investors may also be concerned that the government could be headed for a shutdown later this week. Congress is busy this week trying to pass two bills, which total about $4.5 trillion in spending. Meanwhile, …
3 Solid Growth Stocks Perfect for Retirees
Retired investors may recoil at the mere mention of the word "inflation," because it means the money they've accumulated in their portfolios will buy less and less of the services and items they need. That's one reason why it's important to have some exposure to growth stocks in your portfolio -- they can help counter inflation's erosive impact on the value of your nest egg. To that end, we asked three savvy Motley Fool contributors to recommend growth stocks that they think would be smart additions to any retirement portfolio. Here's why they view Abbott Laboratories ( NYSE:ABT ) , Facebook ( NASDAQ:FB ) , and Rent-A-Center ( NASDAQ:RCII ) as great choices to consider buying now. Image source: Getty Images. A potent mix of income and growth Eric Volkman (Abbott Laboratories): For a great retirement portfolio stock, let's duck into the laboratory -- Abbott Laboratories, that is. A healthcare company with roots going back more than 130 years, …
Continue Reading about 3 Solid Growth Stocks Perfect for Retirees →
Should Peloton Investors Be Worried Right Now?
There are certainly some reasons for Peloton ( NASDAQ:PTON ) investors to worry about revenue growth, such as the company's decision to cut the price of its signature exercise bike, and the reopening of gyms and other exercise facilities across the U.S. In this Fool Live video clip, recorded on Sept. 29 , Fool.com contributor Toby Bordelon discusses whether these headwinds could be temporary or if they're more of a longer-term concern. Toby Bordelon: The quarter itself was good, but there were some warning signs. Revenue growth is slowing with 54% year-over-year which seems good, by compared to the previous four quarters of triple-digit growth not as good. More concerning Peloton set for this next quarter, revenue is going to grow 6%, which not awesome, and gross margins are expected to decline. The bigger news though is they cut their price of their lower tier by $400, that's about a 20% price cut. The concern there is the demand falling off. It might be, but …
Continue Reading about Should Peloton Investors Be Worried Right Now? →
3 Stocks to Watch Heading Into Earnings Season
Earnings season is upon us once again, and while long-term investors shouldn't put too much weight on any company's results from any single quarter, these regular check-ins can certainly give investors more clarity about how businesses and the broader economy are performing. Quarterly reports can also provide insights into the trajectory of a company's growth. This earnings season, I'll be keeping a close eye on a few intriguing stocks, including Silvergate Capital ( NYSE:SI ) , Live Oak Bancshares ( NASDAQ:LOB ) , and Goosehead Insurance ( NASDAQ:GSHD ) . Image source: Getty Images. 1. Silvergate Capital Silvergate Capital started out as a traditional bank, but in 2013, it pivoted to digital currency customers, offering fee-based solutions for people trying to navigate the underdeveloped regulatory environment around cryptocurrencies . This has driven growth for the bank as Bitcoin and other tokens surged in value. Silvergate has grown its total …
Continue Reading about 3 Stocks to Watch Heading Into Earnings Season →
3 Reopening Tech Stocks to Buy in October
The pandemic generated tailwinds for many tech stocks in the e-commerce, cloud, gaming, and remote work markets last year. However, many of those stocks stalled out this year as infection rates declined, vaccination rates rose, and more businesses reopened. As that market sentiment shift continues, investors should pay more attention to tech stocks that should benefit from those reopening trends instead. Let's take a closer look at three of those companies: Impinj ( NASDAQ:PI ) , Adyen ( OTC:ADYE.Y ) , and Airbnb ( NASDAQ:ABNB ) . Image source: Getty Images 1. Impinj Impinj is a leading maker of radio frequency identification (RFID) chips, software, and readers. Before the pandemic struck, Impinj's sales were booming as companies used its RFID chips to modernize their businesses, optimize their supply chains, and connect their infrastructure to the Internet of Things (IoT). Retailers also used its chips to track their products and sales trends to compete …
Continue Reading about 3 Reopening Tech Stocks to Buy in October →
Buy This Stock While It’s Under Wall Street’s Radar
There are a lot of companies out there that don't get the recognition they deserve. In finance, hot fintech stocks and cryptocurrencies are all the rage. Without established name recognition, many solid companies can slip by unnoticed. Live Oak Bancshares ( NASDAQ:LOB ) is a perfect example of a company flying under Wall Street's radar. The regional bank has excelled as the bank for small businesses. This has been a great driver for growth, but what I'm more excited about is the bank's foray into fintech investments and its focus on companies revolutionizing the banking process. America's top small-business lender Live Oak has been crushing it because of its position as a small-business lender . The company can brag about its No. 1 ranking among Small Business Association (SBA) lenders in the country, with $747 million in loans approved through the SBA 7(a) program. It was also named the top commercial-lending partner with the U.S. Department of Agriculture and Rural …
Continue Reading about Buy This Stock While It’s Under Wall Street’s Radar →